• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患有肢端肥大症女性的子宫肌瘤:一项系统评价

Uterine fibroids in women diagnosed with acromegaly: a systematic review.

作者信息

Górski Konrad, Zgliczyński Stanisław, Stelmachowska-Banaś Maria, Czajka-Oraniec Izabella, Zgliczyński Wojciech, Ciebiera Michał, Zgliczyńska Magdalena

机构信息

Second Department of Obstetrics and Gynecology, Centre of Postgraduate Medical Education, Warsaw, Poland.

Department of Internal Medicine and Endocrinology, Medical University of Warsaw, Warsaw, Poland.

出版信息

Rev Endocr Metab Disord. 2024 Aug;25(4):773-781. doi: 10.1007/s11154-024-09883-z. Epub 2024 Apr 26.

DOI:10.1007/s11154-024-09883-z
PMID:38668933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11294406/
Abstract

The review discusses the relationship between acromegaly and uterine fibroids. It highlights variations in research methodologies and inconsistent findings, emphasizing the complex nature of fibroid development and the role of the somatotropic axis. Additionally, it addresses demographic factors and examines the potential impact of therapies on the risk and prevalence of uterine fibroids in individuals with acromegaly. We conducted an analysis of previously published literature that examined the repercussions of acromegaly on gynecological health in female cohorts, with specific attention directed towards elucidating the prevalence of uterine fibroids. We suggest that larger, more focused studies are needed to understand the specific impact of different treatments on the occurrence of gynecological issues in acromegaly patients. Additionally, our study emphasizes the importance of factors such as disease duration and treatment effectiveness. We hypothesize that a relationship between acromegaly and uterine fibroids may occur. However, it remains an area of ongoing research, with the need for larger, multi-center studies to draw more definitive conclusions.

摘要

这篇综述讨论了肢端肥大症与子宫肌瘤之间的关系。它强调了研究方法的差异和不一致的研究结果,强调了肌瘤发生的复杂性以及生长激素轴的作用。此外,它还讨论了人口统计学因素,并研究了治疗方法对肢端肥大症患者子宫肌瘤风险和患病率的潜在影响。我们对之前发表的文献进行了分析,这些文献研究了肢端肥大症对女性队列中妇科健康的影响,特别关注子宫肌瘤的患病率。我们建议需要开展更大规模、更具针对性的研究,以了解不同治疗方法对肢端肥大症患者妇科问题发生情况的具体影响。此外,我们的研究强调了疾病持续时间和治疗效果等因素的重要性。我们推测肢端肥大症与子宫肌瘤之间可能存在关联。然而,这仍然是一个正在进行研究的领域,需要开展更大规模的多中心研究才能得出更明确的结论。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d13/11294406/7a9c2c70f4e9/11154_2024_9883_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d13/11294406/7a9c2c70f4e9/11154_2024_9883_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3d13/11294406/7a9c2c70f4e9/11154_2024_9883_Fig1_HTML.jpg

相似文献

1
Uterine fibroids in women diagnosed with acromegaly: a systematic review.患有肢端肥大症女性的子宫肌瘤:一项系统评价
Rev Endocr Metab Disord. 2024 Aug;25(4):773-781. doi: 10.1007/s11154-024-09883-z. Epub 2024 Apr 26.
2
Selective progesterone receptor modulators (SPRMs) for uterine fibroids.用于子宫肌瘤的选择性孕激素受体调节剂(SPRMs)
Cochrane Database Syst Rev. 2017 Apr 26;4(4):CD010770. doi: 10.1002/14651858.CD010770.pub2.
3
Add-back therapy with GnRH analogues for uterine fibroids.GnRH类似物用于子宫肌瘤的补充治疗。
Cochrane Database Syst Rev. 2015 Mar 20;2015(3):CD010854. doi: 10.1002/14651858.CD010854.pub2.
4
Preoperative medical therapy before surgery for uterine fibroids.子宫肌瘤手术前的术前医学治疗。
Cochrane Database Syst Rev. 2025 Apr 4;4(4):CD000547. doi: 10.1002/14651858.CD000547.pub3.
5
Preoperative medical therapy before surgery for uterine fibroids.子宫肌瘤手术前的术前医学治疗。
Cochrane Database Syst Rev. 2017 Nov 15;11(11):CD000547. doi: 10.1002/14651858.CD000547.pub2.
6
Caesarean myomectomy in pregnant women with uterine fibroids.患有子宫肌瘤的孕妇行剖宫产肌瘤切除术
Cochrane Database Syst Rev. 2025 Jan 27;1(1):CD016119. doi: 10.1002/14651858.CD016119.
7
Association of uterine fibroids with late miscarriage: multicenter cohort study.子宫肌瘤与晚期流产的关联:多中心队列研究
Ultrasound Obstet Gynecol. 2025 Feb;65(2):198-205. doi: 10.1002/uog.29169.
8
Progestogens or progestogen-releasing intrauterine systems for uterine fibroids.用于子宫肌瘤的孕激素或释放孕激素的宫内节育系统。
Cochrane Database Syst Rev. 2013 Feb 28(2):CD008994. doi: 10.1002/14651858.CD008994.pub2.
9
Aromatase inhibitors for uterine fibroids.用于治疗子宫肌瘤的芳香化酶抑制剂。
Cochrane Database Syst Rev. 2013 Oct 23;2013(10):CD009505. doi: 10.1002/14651858.CD009505.pub2.
10
Mifepristone for uterine fibroids.米非司酮用于治疗子宫肌瘤。
Cochrane Database Syst Rev. 2012 Aug 15;2012(8):CD007687. doi: 10.1002/14651858.CD007687.pub2.

本文引用的文献

1
Progesterone signaling in uterine leiomyoma biology: Implications for potential targeted therapy.子宫平滑肌瘤生物学中的孕酮信号传导:对潜在靶向治疗的意义。
Adv Med Sci. 2024 Mar;69(1):21-28. doi: 10.1016/j.advms.2024.01.001. Epub 2024 Jan 25.
2
Endometrial Angiogenesis of Abnormal Uterine Bleeding and Infertility in Patients with Uterine Fibroids-A Systematic Review.子宫肌瘤患者异常子宫出血和不孕的子宫内膜血管生成:系统评价。
Int J Mol Sci. 2023 Apr 10;24(8):7011. doi: 10.3390/ijms24087011.
3
Diagnosis and management of uterine fibroids: current trends and future strategies.
子宫肌瘤的诊断与管理:当前趋势与未来策略
J Basic Clin Physiol Pharmacol. 2023 Mar 30;34(3):291-310. doi: 10.1515/jbcpp-2022-0219. eCollection 2023 May 1.
4
Fertility in Acromegaly: A Single-Center Experience of Female Patients During Active Disease and After Disease Remission.肢端肥大症患者的生育能力:单中心活跃期疾病和疾病缓解后女性患者的经验。
J Clin Endocrinol Metab. 2023 Jul 14;108(8):e583-e593. doi: 10.1210/clinem/dgad042.
5
Hallmarks of cancer: The insulin-like growth factors perspective.癌症的特征:胰岛素样生长因子视角
Front Oncol. 2022 Nov 21;12:1055589. doi: 10.3389/fonc.2022.1055589. eCollection 2022.
6
Uterine Fibroids (Leiomyomata) and Heavy Menstrual Bleeding.子宫肌瘤(平滑肌瘤)与月经过多
Front Reprod Health. 2022 Mar 4;4:818243. doi: 10.3389/frph.2022.818243. eCollection 2022.
7
Evaluating the Impact of Acromegaly on Quality of Life.评估肢端肥大症对生活质量的影响。
Endocrinol Metab Clin North Am. 2022 Dec;51(4):709-725. doi: 10.1016/j.ecl.2022.04.004. Epub 2022 Sep 22.
8
Acromegaly: pathogenesis, diagnosis, and management.肢端肥大症:发病机制、诊断与治疗。
Lancet Diabetes Endocrinol. 2022 Nov;10(11):804-826. doi: 10.1016/S2213-8587(22)00244-3. Epub 2022 Oct 6.
9
The acromegaly lipodystrophy.肢端肥大症性脂肪营养不良。
Front Endocrinol (Lausanne). 2022 Sep 13;13:933039. doi: 10.3389/fendo.2022.933039. eCollection 2022.
10
The prevalence of acromegaly is higher than previously reported: Changes over a three-decade period.肢端肥大症的患病率高于以往报道:三十年期间的变化。
Clin Endocrinol (Oxf). 2022 Dec;97(6):773-782. doi: 10.1111/cen.14828. Epub 2022 Oct 6.